Abstract

BackgroundThe insertion of Ventricular Assist Devices is a common strategy for cardiovascular support in patients with refractory cardiogenic shock. This study sought to determine the impact of ventricular assist devices on the dynamic relationship between arterial blood pressure and cerebral blood flow velocity.MethodsA sample of 5 patients supported with a pulsatile ventricular assist device was compared with 5 control patients. Controls were matched for age, co-morbidities, current diagnosis and cardiac output state, to cases. Beat-to-beat recordings of mean arterial pressure and cerebral blood flow velocity, using transcranial Doppler were obtained. Transfer function analysis was performed on the lowpass filtered pressure and flow signals, to assess gain, phase and coherence of the relationship between mean arterial blood pressure and cerebral blood flow velocity. These parameters were derived from the very low frequency (0.02-0.07 Hz), low frequency (0.07-0.2 Hz) and high frequency (0.2-0.35 Hz).ResultsNo significant difference was found in gain and phase values between the two groups, but the low frequency coherence was significantly higher in cases compared with controls (mean ± SD: 0.65 ± 0.16 vs 0.38 ± 0.19, P = 0.04). The two cases with highest coherence (~0.8) also had much higher spectral power in mean arterial blood pressure.ConclusionsPulsatile ventricular assist devices affect the coherence but not the gain or phase of the cerebral pressure-flow relationship in the low frequency range; thus whether there was any significant disruption of cerebral autoregulation mechanism was not exactly clear. The augmentation of input pressure fluctuations might contribute in part to the higher coherence observed.

Highlights

  • The insertion of Ventricular Assist Devices is a common strategy for cardiovascular support in patients with refractory cardiogenic shock

  • No significant difference in mean arterial blood pressure (MAP), pCO2 and LVEF was found between the Ventricular assist devices (VAD) and the control groups

  • LVEF was generally lower for the VAD cases, whichwas expected as these were patients with baseline refractory cardiogenic shock who required a VAD for life support

Read more

Summary

Introduction

The insertion of Ventricular Assist Devices is a common strategy for cardiovascular support in patients with refractory cardiogenic shock. Ventricular assist devices (VAD) are mechanical pumps that replace or augment left and/or right ventricular function in cases of refractory cardiogenic shock. Fundamental differences regarding cardiac output and systemic circulation distinguish two main types of VAD: pulsatile and continuous-flow VAD. Pulsatile circulation and its effects on systemic vascular resistances have been related to the improvement of microcirculation and endothelial integrity [6,7]; reduction in splanchnic perfusion and reduction of intestinal edema [8]; improvement of the cerebral haemodynamics and cerebrospinal fluid drainage [2] and the maintenance of neuro-endocrine cascades, within the renin-angiotensine system and catecholamine release [5]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call